Sunday, June 15th, 2025

Author: minichart

🚨 This 1.5-cent stock has hit rock bottom — but a 60% rebound could be on the horizon! 📈 Join the Minichart seminar to uncover what’s next.

📈 Singtel Posts $4.02B FY2025 Profit, Powered by HQ Divestment & Operational Gains Z74.SI (Singapore Telecommunications Ltd) Singtel (Z74.SI) has reported a 405% year-on-year surge in FY2025 net profit to S$4.02 billion, boosted by...

Which Singapore penny stock will surge by 40% within the next 2 weeks?

🚨 From Boardroom Battles to Billion-Dollar Buyouts: SG Market on Fire! 🔥 SGX: CEDU 👀 Drama at Dasin Retail Trust! Trustee-manager claps back at ex-director Zhang Zhongming’s claims of being ignored and mismanagement. Says...

Trade Tensions Rise Again

1. Wall Street Wrap Wall St ends the week flying high! SPX +0.70%, IXIC +0.52%, DJI +0.78%. Weekly gains? Nasdaq +7.2% S&P +5.3% Dow +3.4% Tech flexed: NVDA +16% META +8% AAPL +6% MSFT...

🏥 Healthcare S-REITs Outperform in 2025, Defying Broader Market Weakness

Healthcare S-REITs have emerged as the top-performing sub-sector in 2025, delivering an average total return of 6.2% year-to-date—significantly outperforming the broader iEdge S-REIT Index, which fell 1.1%. Over one- and three-year periods, the...

🎯 Genting Singapore (SGX: G13) Seen as Undervalued Despite Profit Drop, CEO Exit

Genting Singapore (SGX: G13) remains undervalued despite posting weaker earnings and the surprise announcement that CEO Tan Hee Teck will step down on May 31, according to analysts. The company reported a 20% drop...

Chinese Firms Eye Singapore Listings Amid Rising US Trade Tensions

At least five companies from mainland China and Hong Kong are exploring IPOs, dual listings, or share placements on the Singapore Exchange (SGX) over the next 12 to 18 months, according to four sources...

Mirxes’ HK IPO: Pioneering miRNA Diagnostics with Strong Investor Backing

1. IPO Details Purpose of IPO: Mirxes aims to raise approximately HKD 1.086 billion (USD 139 million) through its IPO. The proceeds are intended to support the commercialization of its gastric cancer test, further...

Hengrui Pharma’s HK$9.89 Billion IPO: A Strategic Move to Cement Global Pharmaceutical Leadership

IPO Details Purpose of IPO: Hengrui Pharma aims to raise up to HK$9.89 billion (US$1.27 billion) through its Hong Kong listing. The proceeds are allocated as follows: Approximately 45% for funding clinical studies of...

PEOPLElogy Berhad’s RM26.25 Million IPO: Pioneering Digital Talent Development Across Southeast Asia

IPO Details Purpose of IPO: PEOPLElogy aims to raise RM26.25 million through the issuance of 105 million new shares at RM0.25 each. The proceeds are allocated as follows: Expansion into East Malaysia and Southeast...

Eco-Shop’s RM420 Million IPO: Malaysia’s Discount Retail Giant Sets Sights on Expansion

 IPO Details Purpose of IPO: Eco-Shop aims to raise approximately RM419.87 million through the issuance of 347 million new shares. The proceeds are allocated as follows: RM56.27 million (13.4%) for expanding its retail footprint...